SK bioscience
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 20:00
SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia 2024-10-23 15:11
Korea's SK bioscience Acquires Stake in U.S. Biotech Fina Biosolutions 2024-10-08 20:00
South Korea's SK bioscience Completes Acquisition of Germany's CDMO IDT Biologika 2024-10-02 20:00
SK bioscience Exports Influenza Vaccine to Thailand, Entering Southern Hemisphere Market 2024-03-21 13:24
SK bioscience Presents Solution for Equitable Access of Vaccine at Regionalized Vaccine Manufacturing Collaborative of World Economic Forum 2023-05-23 20:00
SK bioscience Announces the Largest Investment Ever to Establish Songdo Global Research & Process Development Center 2023-02-08 20:00
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs 2023-01-27 20:00
SK bioscience Appoints New Executives to Accelerate New Growth Strategies 2023-01-20 20:00
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia 2023-01-09 21:00
SK bioscience and CEPI Sign Agreement to Develop mRNA Vaccines 2022-10-25 20:00
SK bioscience Appoints New Executives towards Global Business Growth 2022-10-21 20:00
1